NEOS Investment Management LLC raised its position in Ventas, Inc. (NYSE:VTR – Free Report) by 16.0% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 174,633 shares of the real estate investment trust’s stock after acquiring an additional 24,150 shares during the quarter. NEOS Investment Management LLC’s holdings in Ventas were worth $15,507,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of the business. Dynamic Wealth Strategies LLC purchased a new position in Ventas during the first quarter valued at $25,000. Silvant Capital Management LLC purchased a new stake in Ventas during the 2nd quarter valued at approximately $28,000. Meeder Asset Management Inc. bought a new stake in Ventas in the 2nd quarter valued at $30,000. Wiser Advisor Group LLC bought a new stake in shares of Ventas in the third quarter worth about $27,000. Finally, IFC & Insurance Marketing Inc. purchased a new stake in shares of Ventas during the 4th quarter worth approximately $30,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.
Ventas Trading Down 2.0%
NYSE:VTR opened at $90.27 on Friday. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The business’s 50 day moving average is $92.94 and its two-hundred day moving average is $87.82. Ventas, Inc. has a 52 week low of $66.38 and a 52 week high of $101.60. The company has a market cap of $46.30 billion, a PE ratio of 167.17, a P/E/G ratio of 3.59 and a beta of 0.70.
Analyst Upgrades and Downgrades
A number of brokerages recently commented on VTR. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $110.00 price target on shares of Ventas in a report on Tuesday, May 19th. Citigroup upped their price target on shares of Ventas from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Tuesday, August 4th. Jefferies Financial Group raised their price objective on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, May 12th. Raymond James Financial began coverage on shares of Ventas in a report on Tuesday, June 16th. They issued an “outperform” rating and a $94.00 price target for the company. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $100.00 price objective on shares of Ventas in a research note on Tuesday, June 16th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $99.00.
Get Our Latest Analysis on Ventas
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Stories
- Five stocks we like better than Ventas
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
